In this issue:
High frequencies of RASs to NS5A inhibitors in genotype 3 HCV
Developing an effective vaccine against HCV infection
Pevonedistat shows promise in chronic HBV infection
Survival rates in renal transplant recipients with HBV/HCV
Do DAAs accelerate overt HCC emergence in cirrhosis?
A novel HBx genotype determines prognosis in HBV-related HCC?
HBcrAg linked to cccDNA transcriptional activity in chronic HBV
DAAs for chronic HCV infection safe in patients with prior HCC
CD8+ T cells in HDV infection
Viral escape from HDV-specific CD8+ T cells
Please login below to download this issue (PDF)